24.74
-0.16
-0.64%
-0.16
-0.64%
MORE ON POAGX
DETAILS
| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 24.90 |
| Category | Mid-Cap Growth |
| Net Assets | 3.04 Bil |
| Yield | 0.00% |
| Morningstar Risk | Above Average |
| Morningstar Return | High |
- Last NAV update 6/19/2013 11:27 PM ET
INVESTMENT OBJECTIVE
| NA |
|---|
| The investment seeks to provide long-term capital appreciation. The fund invests primarily in the common stocks of U.S. companies, emphasizing those companies with prospects for rapid earnings growth. It may invest in stocks across all market sectors and market capitalizations and has historically invested significant portions of its assets in mid- and small-capitalization companies. |
CUMULATIVE PERFORMANCE OF $10,000
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | 50.43% | 21.57% | -0.45% | 21.22% | 27.00% |
| Value ($) | 15,043.01 | 18,287.64 | 18,204.49 | 22,067.42 | 28,026.08 |
- Year to date performance as of 6/19/2013 12:00 AM ET
MANAGEMENT & PURCHASE INFO
| Symbol | Value ($) |
|---|---|
| Fund Family | PRIMECAP Odyssey Funds |
| Fund Manager | Alfred Mordecai |
| Tenure (Years) | 9 |
| Fund Status | Open |
| Minimum Initial Purchase | 2,000.00 |
| Minimum IRA Investment | 1,000.00 |
| Front Load | 0.00 |
| Expense Ratio | 0.68% |
PERFORMANCE
| Symbol | Value ($) |
|---|---|
| 1 Month | 1.69% |
| 3 Months | 11.14% |
| 1 Year | 34.24% |
| 3 Years* | 20.79% |
| 5 Years* | 14.27% |
- * Annualized returns
- Performance as of 6/19/2013 12:00 AM ET
PEER COMPARISON
| POAGX | Mid-Cap Growth | |
|---|---|---|
| 5-Yr Return | 14.27% | 5.26% |
| Sharpe Ratio | 1.13 | 2.75 |
| Net Assets | 3.04 Bil | 378.08 Mil |
| Avg Market Cap | 4.49 Bil | 7.09 Bil |
| Avg P/E | 20.78 | 19.00 |
| Portfolio Turnover | 14 | 67 |
HOLDINGS
| Symbol | Value ($) |
|---|---|
| Stocks | 90.08% |
| Cash | 9.92% |
| Fixed Income | 0.00% |
| Other | 0.00% |
TOP 10 HOLDINGS
| NAME | % NET ASSETS |
|---|---|
| Pharmacyclics, Inc. | 4.46% |
| Seattle Genetics, Inc. | 4.19% |
| Roche Holding AG | 4.01% |
| Dreamworks Animation SKG, Inc. | 3.14% |
| Immunogen, Inc. | 2.35% |
| Google, Inc. Class A | 2.31% |
| Abiomed, Inc. | 2.01% |
| Shutterfly, Inc. | 1.96% |
| Adobe Systems Inc | 1.92% |
| comScore, Inc. | 1.87% |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
RECENT QUOTES
WATCHLIST
You're not signed in
You’re not signed in to MSN Money, so you’re seeing the Watchlist that is tied to your computer. For a more consistent Watchlist experience, sign in to MSN Money.
Learn more
Sponsored by:
MARKET UPDATE
[BRIEFING.COM] Equities ended on their lows with the S&P 500 down 1.4%. The S&P entered today's session with a week-to-date gain of 1.5% as investors expected reassuring words from today's Federal Open Market Committee Statement. Stocks traded with s
...
More
MORE MARKET NEWS
Sponsored by:
INVESTING TIPS AND TOOLS